One dose of the human papillomavirus (HPV) vaccine is enough to protect against cervical cancer, a
The WHO Strategic Advisory Group of Experts on Immunization, known as SAGE, said single-dose schedules of the HPV vaccine provide comparable efficacy to two or three-dose schedules.
A single dose of the vaccine offers “solid protection against HPV, the virus that causes cervical cancer,” SAGE and the WHO said in a statement. The efficacy of a one-dose HPV vaccine “could be a game-changer,” for the prevention of the disease often referred to as the ‘silent killer,’ they said. ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.